Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 49-53 , 15 July 2003

The prevalence and clinical characteristics of MS in northern Japan

  • Hideki Houzen

      Affiliations

    • Department of Neurology, Obihiro Kosei General Hospital, Obihiro, Japan
    • These authors contributed equally to this work.
    • ,
  • Masaaki Niino

      Affiliations

    • Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-ku, Sapporo 060-8638, Japan
    • These authors contributed equally to this work.
    • ,
  • Seiji Kikuchi

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +81-11-706-6028; fax: +81-11-700-5356.
    • Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-ku, Sapporo 060-8638, Japan
    • ,
  • Toshiyuki Fukazawa

      Affiliations

    • Hokuyukai Neurology Hospital, Sapporo, Japan
    • ,
  • Shinji Nogoshi

      Affiliations

    • Department of Neurology, Obihiro Kosei General Hospital, Obihiro, Japan
    • ,
  • Hiroyuki Matsumoto

      Affiliations

    • Department of Neurology, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Kunio Tashiro

      Affiliations

    • Department of Neurology, Hokkaido University Graduate School of Medicine, Kita-15 Nishi-7, Kita-ku, Sapporo 060-8638, Japan

Received 14 November 2002 ,Revised 4 February 2003 ,Accepted 5 February 2003.

References 

  1. Johnson RT. The virology of demyelinating diseases. Ann. Neurol. 1994;36(Suppl.):S54–S60
  2. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci. 2001;22:117–139
  3. Okinaka S, Reese HH, Katsuki S, et al.  The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol. Scand. 1966;19:68–76
  4. Kuroiwa Y, Shibasaki H, Ikeda M. Prevalence of multiple sclerosis and its north-to-south gradient in Japan. Neuroepidemiology. 1983;2:62–69
  5. Shibasaki H, Kuroda Y, Kuroiwa Y. Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease. J. Neurol. Sci. 1974;23:215–222
  6. Kuroiwa Y, Igata A, Itahara K, Koshijima S, Tsubaki T. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology. 1975;25:845–851
  7. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J. Neurol. Sci. 1981;49:253–271
  8. Shibasaki H, Kubo N, Nishitani H, Saida T, Ohno Y, Fukuyama Y. Nationwide survey of multiple sclerosis in Japan: reappraisal of clinical features. J. Trop. Geogr. Neurol. 1992;2:73–82
  9. Fukazawa T, Tashiro K, Hamada T, et al.  Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern. Med. 1992;31:349–352
  10. Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983;13:227–231
  11. Schoenberg BS. Calculating confidence interval for rates and ratios. Neuroepidemiology. 1983;2:257–265
  12. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  13. Paty DW, Noseworthy JH, Ebers GC. Diagnosis of multiple sclerosis. In:  Paty DW,  Ebers GC editor. Multiple Sclerosis. Philadelphia: FA Davis; 1997;p. 55–56
  14. Yu YL, Woo E, Hawkins BR, Ho HC, Huang CY. Multiple sclerosis amongst Chinese in Hong Kong. Brain. 1989;112:1445–1467
  15. Lau KK, Wong LK, Li LS, Chan YW, Li HL, Wong V. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med. J. 2002;8:77–80
  16. Alter M, Okihiro M, Rowley W, Morris T. Multiple sclerosis among Orientals and Caucasians in Hawaii. Neurology. 1971;21:122–130
  17. Kurland LT. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity survey in the United States and Canada. Am. J. Hyg. 1952;55:457–476
  18. Roth MP, Ballivet S, Descoins P, et al. Multiple sclerosis in Pyrenees–Atlantiques: a case-control study conducted in the southwest of France. In: Firnhaber W, Lauer K, editors. Multiple sclerosis in Europe: an epidemiological update. Darmstadt: Leuchtturm-Verlag/LTV Press; 1994. p. 177–8.
  19. Kurtzke JF. Geography in multiple sclerosis. J. Neurol. 1977;215:1–26
  20. Compston A. Genetic epidemiology of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 1997;62:553–561
  21. Okinaka S, Kuroiwa Y. Multiple sclerosis and allied diseases in Japan: epidemiologic and clinical aspects. Prog. Brain Res. 1966;21:183–191
  22. Kuroiwa Y, Hung TP, Landsborough D, Park CS, Singhal BS. Multiple sclerosis in Asia. Neurology. 1977;27:188–192
  23. Yamasaki K, Horiuchi I, Minohara M, et al.  HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain. 1999;122:1689–1696
  24. Kira J, Yamasaki K, Hoiuchi I, Ohyagi Y, Taniwaki T, Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J. Neurol. Sci. 1999;166:53–57
  25. Fukazawa T, Kikuchi S, Niino M, et al.  Clinical and immunological heterogeneity in Japanese MS: distinct characteristics of MS showing acute transverse myelopathy and the optico-spinal form of MS, and heterogeneity of conventional MS. Neuroimmunology. 1999;7:181–187 (in Japanese)

PII: S0022-510X(03)00033-9

doi: 10.1016/S0022-510X(03)00033-9

Journal of the Neurological Sciences
Volume 211, Issue 1 , Pages 49-53 , 15 July 2003

Article Tools

* Image Usage & Resolution